Hostname: page-component-78c5997874-94fs2 Total loading time: 0 Render date: 2024-11-13T04:43:14.081Z Has data issue: false hasContentIssue false
  • English
  • Français

Comparison of Inhaled Metaproterenol via Metered-dose and Hand-held Nebulization in Prehospital Treatment of Bronchospasm

Published online by Cambridge University Press:  28 June 2012

Steven J. Rottman ,
Nancy E. Robinson  and
Marvin L. Birnbaum
Steven J. Rottman*
Affiliation:
Emergency Medicine Center, University of California - Los Angeles Medical Center, Los Angeles, California
Nancy E. Robinson
Affiliation:
Emergency Medical Services Program, University of Wisconsin-Madison, Madison, Wisconsin
Marvin L. Birnbaum
Affiliation:
Emergency Medical Services Program, University of Wisconsin-Madison, Madison, Wisconsin
*
Emergency Medicine Center, University of California at Los Angeles, 10833 Le Conte Avenue, Los Angeles, CA 90024, USA
Get access Rights & Permissions [Opens in a new window]

Abstract

Introduction:

Although the efficacy of the administration of beta-adrenergic bronchodilators has been demonstrated, the best method available for the delivery of these drugs in the prehospital setting has not been defined. This paper compares the effects of administration of metaproterenol when administered by paramedics using either a metered-dose inhaler (MDI) or a hand-held nebulizer (HHN).

Hypothesis:

There is no difference in the effects produced in patients suffering from smooth bronchiolar muscle spasm by metaproterenol when delivered either by a standard metered-dose inhaler or with a hand-held nebulizer.

Participants:

Consecutive prehospital patients complaining of difficulty breathing with clinical evidence of bronchospasm and with a history of asthma, chronic obstructive pulmonary disease, or emphysema who were not in extremis.

Methods:

Prior to the administration of metaproterenol, a peak expiratory flow rate (PEFR) was obtained. This measurement was repeated five minutes following the conclusion of the administration of metaproterenol. Patients in Burbank, California, received the treatment using a standard metered-dose inhaler, and those in Madison, Wisconsin, received the drug using a hand-held nebulizer. Peak expiratory flow rates were compared using Student's t-tests with Bonferroni's correction. Statistical significance was set at p <0.05.

Results:

Data were collected from 36 consecutive patients by the paramedics of the Burbank Fire Department and from 32 consecutive patients by the paramedics of the Madison Fire Department. For the metered-dose inhaler group, the mean value for peak expiratory flow rate for the pre-treatment test was 95.4 ±88.1 1/min, and after treatment was 109.4 ±89.3 1/min (p <0.001). For the hand-held nebulizer group, the mean value for peak expiratory flow rate before the administration of the metaproterenol was 96.1 ±76.3 1/min and following the treatment was 149.1 ±92.9 1/min (p <0.001). The mean values for the differences between the control peak expiratory flow rate and the post-treatment peak expiratory flow rate for the metered-dose inhaler group was +14.0 ±27.4 1/min, and for the hand-held nebulizer group was +53.0 ±69.1 1/min (p <0.003).

Conclusions:

In the prehospital setting the administration of metaproterenol using a hand-held nebulizer is more effective than delivering the drug using a metered-dose inhaler. The hand-held nebulizer is easier to use and delivers a higher dose of the drug than is convenient using the metered-dose inhaler.

Keywords

ageAlbuterol Alupentasthmabeta agonistsbeta-2bronchospasmchronic obstructive pulmonary diseasedyspneaemergency medical servicesemphysemahand-held nebulizerinhalermetaproterenolmetered-dosenebulizerparamedicpeak expiratory flow rateprehospital
Type
Original Research
Information
Prehospital and Disaster Medicine , Volume 11 , Issue 4 , December 1996 , pp. 280 - 284
Copyright
Copyright © World Association for Disaster and Emergency Medicine 1996

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Jenkins, SC, Heaton, RW, Fulton, TJ, et al. : Comparison of domiciliary nebulized Salbutamo and Salbutamol from a metered-dose inhaler in stable chronic airflow limitation. Chest 1987;91:801–807.CrossRefGoogle Scholar
2. Newhouse, MT, Dolovich, MB: Control of asthma by aerosols. N Engl J Med 1986;315:870–874.CrossRefGoogle ScholarPubMed
3. Morgan, MDL, Sing, BV, Frame, MH, et al. : Terbutaline aerosol given through pear spacer in acute asthma. BMJ 1982;285:849–50.CrossRefGoogle Scholar
4. Hawkins, J, Hakala, K, Heller, MB, et al. : Metered-dose aerosolized bronchodilators in prehospital care: A feasibility study. J Emerg Med 1986;4:273–77.CrossRefGoogle ScholarPubMed
5. Newhouse, MT, Dolovich, MD: Aerosol therapy: Nebulizer vs metereddose inhaler. Chest 1987;91:799–800.CrossRefGoogle Scholar